e-Drug3D 853 |
cas 53123-88-9 |
CLASS ANTINEOPLASTIC |
ROUTE (list) ORAL INTRAVENOUS TOPICAL |
NATURAL MOLECULE (link) | PK parameters F 14 PERCENT Solubility INSOLUBLE IN WATER |
Target TARGET FK BINDING PROTEIN-12 (FKBP-12) PDB Ligand code = RAP (link to the list of PDB complexes) Download experimental 3D coordinates of RAP with added hydrogens |
DrugCentral Peptidyl-prolyl cis-trans isomerase FKBP1A UNIPROT P62942 FKBP1A |
Download SDF file | Rapamycin Formula: Calculated chemical properties: MW 914.15 NB_atoms 65 XLogP 6.18 PSA 166.856 NB_HD 3 NB_HA 14 fsp3 0.75 Lipinski(0=no;1=yes) 0 |
FDA NDA 021083 (label) INN (SIROLIMUS) RAPAMUNE (PF PRISM CV) APPROVAL= AP YEAR= 1999 NDA 021110 (label) INN (SIROLIMUS) RAPAMUNE (PF PRISM CV) APPROVAL= AP YEAR= 2000 NDA 201578 (pdf not found) INN (SIROLIMUS) SIROLIMUS (DR REDDYS) APPROVAL= AP YEAR= 2014 NDA 201676 (pdf not found) INN (SIROLIMUS) SIROLIMUS (ZYDUS PHARMS) APPROVAL= AP YEAR= 2014 NDA 211040 (pdf not found) INN (SIROLIMUS) SIROLIMUS (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2019 NDA 211212 (pdf not found) INN (SIROLIMUS) SIROLIMUS (AMNEAL) APPROVAL= AP YEAR= 2019 NDA 211406 (pdf not found) INN (SIROLIMUS) SIROLIMUS (APOTEX) APPROVAL= AP YEAR= 2019 NDA 208691 (pdf not found) INN (SIROLIMUS) SIROLIMUS (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2020 NDA 214753 (pdf not found) INN (SIROLIMUS) SIROLIMUS (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021 NDA 213312 (label) INN (SIROLIMUS) FYARRO (AADI SUB) APPROVAL= AP YEAR= 2021 NDA 215016 (pdf not found) INN (SIROLIMUS) SIROLIMUS (TORRENT) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 213478 (label) INN (SIROLIMUS) HYFTOR (NOBELPHARMA) APPROVAL= AP YEAR= 2022 NDA 216728 (pdf not found) INN (SIROLIMUS) SIROLIMUS (MSN) APPROVAL= AP YEAR= 2023 NDA 215080 (pdf not found) INN (SIROLIMUS) SIROLIMUS (HETERO LABS LTD V) APPROVAL= AP YEAR= 2024 NDA 215116 (pdf not found) INN (SIROLIMUS) SIROLIMUS (RISING) APPROVAL= AP YEAR= 2025 |
Other links: |